TY - JOUR
T1 - Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection
T2 - A multi-center case-control study from India
AU - Jayaswal, Sneha Kumar
AU - Singh, Shalendra
AU - Malik, Prabhat Singh
AU - Venigalla, Sri Krishna
AU - Gupta, Pallavi
AU - Samaga, Shreyas N.
AU - Hota, Rabi Narayan
AU - Bhatia, Surinder Singh
AU - Gupta, Ishaan
N1 - Publisher Copyright:
© 2021 Diabetes India
PY - 2021/9/1
Y1 - 2021/9/1
N2 - Aims: This study aims to find a quantitative association between the presence of co-existing diabetes mellitus (DM) and/or hypertension (HTN) with COVID-19 infection severity and mortality. Methods: A total of 813 patients with a positive COVID-19 were included. A case-control design was used to dissect the association between DM and HTN with COVID-19 severity and mortality. Results: According to MOHFW guidelines, 535 (65.7%) patients had mild, 160 (19.7%) patients had moderate, and 118 (14.5%) patients had severe disease outcomes including mortality in 52 patients. Age, Neutrophil%, and Diabetes status were significantly associated with severe COVID-19 infection. After adjusting for age, patients with diabetes were 2.46 times more likely to have severe disease (Chi-squared = 18.89, p-value<0.0001) and 2.11 times more likely to have a fatal outcome (Chi-squared = 6.04, p-value = 0.014). However, we did not find evidence for Hypertension modifying the COVID-19 outcomes in Diabetic patients. Conclusion: COVID-19 severity and mortality both were significantly associated with the status of DM and its risk may not be modified by the presence of HTN.
AB - Aims: This study aims to find a quantitative association between the presence of co-existing diabetes mellitus (DM) and/or hypertension (HTN) with COVID-19 infection severity and mortality. Methods: A total of 813 patients with a positive COVID-19 were included. A case-control design was used to dissect the association between DM and HTN with COVID-19 severity and mortality. Results: According to MOHFW guidelines, 535 (65.7%) patients had mild, 160 (19.7%) patients had moderate, and 118 (14.5%) patients had severe disease outcomes including mortality in 52 patients. Age, Neutrophil%, and Diabetes status were significantly associated with severe COVID-19 infection. After adjusting for age, patients with diabetes were 2.46 times more likely to have severe disease (Chi-squared = 18.89, p-value<0.0001) and 2.11 times more likely to have a fatal outcome (Chi-squared = 6.04, p-value = 0.014). However, we did not find evidence for Hypertension modifying the COVID-19 outcomes in Diabetic patients. Conclusion: COVID-19 severity and mortality both were significantly associated with the status of DM and its risk may not be modified by the presence of HTN.
KW - COVID-19
KW - Co-morbidities
KW - Diabetes mellitus
KW - Hypertension
KW - Mortality
KW - Severity
UR - http://www.scopus.com/inward/record.url?scp=85112547377&partnerID=8YFLogxK
U2 - 10.1016/j.dsx.2021.102248
DO - 10.1016/j.dsx.2021.102248
M3 - Article
C2 - 34412000
AN - SCOPUS:85112547377
SN - 1871-4021
VL - 15
JO - Diabetes and Metabolic Syndrome: Clinical Research and Reviews
JF - Diabetes and Metabolic Syndrome: Clinical Research and Reviews
IS - 5
M1 - 102248
ER -